TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Technology Industry News CytoReason secures $80m investment to expand disease modeling technologies In a significant boost for the field of computational disease modeling, CytoReason announced an $80 million investment led… byPallavi MadhirajuJuly 17, 2024